Cholesterol levels in panic disorder, generalized anxiety disorder and major depression

Serum plasma total cholesterol levels were measured in 85 male or female outpatients with panic disorder (PD; N=41), generalized anxiety disorder (GAD; N=23) and major depression (MD; N=21) according to DSM-IV criteria. All the patients had a mean cholesterol level within the normal range; males (N=22) and females (N=63) had approximately the same serum cholesterol levels (p > .05). No significant differences in cholesterol levels emerged between PD, GAD and MD patient groups. Both female PD and female GAD subjects had a mean cholesterol level similar to their male counterparts (p>.05). It is concluded that both Hayward and colleagues and Bajwa et al. findings could not be replicated by our study.

Download Full-text

The effects of maternal major depression, generalized anxiety disorder, and panic disorder on birth weight and gestational age: A comparative study

Journal of Psychosomatic Research ◽

10.1016/j.jpsychores.2013.02.008 ◽

2013 ◽

Vol 75 (1) ◽

pp. 87-89 ◽

Cited By ~ 29

Author(s):

Faruk Uguz ◽

Mine Sahingoz ◽

Erdem Onder Sonmez ◽

Cagatay Karsidag ◽

Goksen Yuksel ◽

...

Keyword(s):

Birth Weight ◽

Anxiety Disorder ◽

Major Depression ◽

Panic Disorder ◽

Comparative Study ◽

Generalized Anxiety Disorder ◽

Gestational Age ◽

Generalized Anxiety

Download Full-text

Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study

European Psychiatry ◽

10.1016/j.eurpsy.2004.09.035 ◽

2005 ◽

Vol 20 (3) ◽

pp. 229-235 ◽

Cited By ~ 51

Author(s):

Marc Ansseau ◽

Benjamin Fischler ◽

Michel Dierick ◽

Annick Mignon ◽

Sophie Leyman

Keyword(s):

Primary Care ◽

Anxiety Disorder ◽

Major Depression ◽

Generalized Anxiety Disorder ◽

Large Scale ◽

Screening Program ◽

Generalized Anxiety ◽

French Speaking ◽

Dsm Iv ◽

Large Scale Screening

AbstractPurposeGADIS aims at determining the prevalence of generalized anxiety disorder (GAD) and major depression (MD) in primary care and their impact on the patient’s functioning in Belgium and Luxemburg.MethodsA large scale screening program was conducted at the consultation of general practitioners to detect patients with GAD and MD according to DSM-IV criteria. We collected additional data regarding the use of hypnotic, tranquilizer, antidepressant and analgesic medications. Impact on the patient was assessed with the Sheehan disability scale.ResultsThree hundred GP’s in Belgium and Luxemburg were asked to screen 50 consecutive patients. Of the 13,677 analyzed patients, 8.3% were diagnosed to have GAD and 6.3% MD. Comorbidity was observed in 4.2% of patients. The prevalence was much higher in the French-speaking part of Belgium. GAD and MD were associated with impairment in social, familial and professional functioning. Only a minority of patients with GAD and/or MD was treated with an antidepressant and almost half of subjects with GAD and/or MD were treated with a tranquilizer.ConclusionsPrevalence rates of GAD and MD in primary care in Belgium are comparable to other countries. GAD and MD are disabling conditions. Antidepressants are still used only in a minority of subjects with GAD and/or MD in primary care in Belgium and Luxemburg. The prevalence of GAD and MD appears to be much higher in French-speaking parts of Belgium.

Download Full-text

Major Depression, Generalized Anxiety Disorder, and Panic Disorder in Patients Scheduled for Knee Arthroplasty

The Journal of Arthroplasty ◽

10.1016/j.arth.2009.04.002 ◽

2010 ◽

Vol 25 (4) ◽

pp. 581-588 ◽

Cited By ~ 19

Author(s):

Daniel L. Riddle ◽

James B. Wade ◽

William A. Jiranek

Keyword(s):

Anxiety Disorder ◽

Major Depression ◽

Panic Disorder ◽

Generalized Anxiety Disorder ◽

Knee Arthroplasty ◽

Generalized Anxiety

Download Full-text

Association of aMAOAgene variant with generalized anxiety disorder, but not with panic disorder or major depression

American Journal of Medical Genetics Part B Neuropsychiatric Genetics ◽

10.1002/ajmg.b.10013 ◽

2001 ◽

Vol 117B (1) ◽

pp. 1-6 ◽

Cited By ~ 72

Author(s):

A. Tadic ◽

D. Rujescu ◽

A. Szegedi ◽

I. Giegling ◽

P. Singer ◽

...

Keyword(s):

Anxiety Disorder ◽

Major Depression ◽

Panic Disorder ◽

Generalized Anxiety Disorder ◽

Generalized Anxiety

Download Full-text

Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder

American Journal of Psychiatry ◽

10.1176/ajp.151.2.205 ◽

1994 ◽

Vol 151 (2) ◽

pp. 205-209 ◽

Cited By ~ 36

Keyword(s):

Anxiety Disorder ◽

Major Depression ◽

Panic Disorder ◽

Generalized Anxiety Disorder ◽

Generalized Anxiety

Download Full-text

Serum Cholesterol Levels in Patients with Generalized Anxiety Disorder (GAD) and with GAD and Comorbid Major Depression

The Canadian Journal of Psychiatry ◽

10.1177/070674379604100712 ◽

1996 ◽

Vol 41 (7) ◽

pp. 465-468 ◽

Cited By ~ 21

Author(s):

Andrzej R Kuczmierczyk ◽

James G Barbee ◽

Nancy A Bologna ◽

Mark H Townsend

Keyword(s):

Cardiovascular Disease ◽

Anxiety Disorder ◽

Major Depression ◽

Generalized Anxiety Disorder ◽

Serum Cholesterol ◽

Generalized Anxiety ◽

Lipid Levels ◽

Cholesterol Levels

Objective: To investigate risk for cardiovascular disease inpatients with GAD, as well as the effects of comorbid major depression (MD). Method: Predrug-trial serum cholesterol and triglyceride levels were assessed in 38 patients with pure GAD and compared with those of 21 patients with mixed GAD and comorbid (MD). Results: Significantly higher cholesterol and triglyceride levels were found in the GAD group. Conclusion: Increased noradrenergic activity may be responsible for elevations in lipid levels in patients with pure GAD.

Download Full-text